Patient Age, Use of Checkpoint Inhibitors in Cancer Linked to COVID-19 Severity
Cancer is among the underlying conditions that increase risk for COVID-19.
COVID19
Society of Gynecologic Oncology Publishes COVID-19 Guidelines
The Society of Gynecologic Oncology published recommendations to guide clinicians through shared decision making with patients about anticancer treatment.
Clotting and COVID: New Guidelines in the Works to Treat Coagulopathies in Patients With COVID-19
Growing concerns about thromboembolic comorbidities in patients with COVID-19 is leading ASH to create clinical practice guidelines to treat this patient population.
COVID-19 Impacts Oncology Clinical Trials
American Society of Clinical Oncology survey shows that the COVID-19 pandemic has created challenges in how oncology clinical trials are conducted, but lessons learned from the experience could lead to more efficiently conducted trials after the pandemic has waned.
Distinguishing Interstitial Lung Disease From COVID-19 Infection in Patients Treated With EGFR-TKIs
Optimal treatment of patients with EGFR-TKI–associated ILD is based on rapid diagnosis and the timely implementation of specific interventions.
Pediatric Oncology Care Providers Encouraged to Share Data on Patients With COVID-19
An international registry dedicated to pediatric patients with cancer infected with COVID-19 was made possible through an international collaboration.
Radiation Therapy for Hematologic Cancers During the COVID-19 Pandemic
ILROG has issued guidelines on alternative radiation treatment methods to combat limited treatment resources for cancer patients during the COVID-19 pandemic.
Tocilizumab Shows Benefit in a Patient With COVID-19 and Multiple Myeloma
IL-6 blockade may have helped a patient with multiple myeloma recover from COVID-19, but larger studies are needed to prove efficacy.
A Call to Investigate IL-17 as Drug Target for Lung Cancer, COVID-19
Interleukin 17 may be a therapeutic target worth investigating for patients with lung cancer and SARS-CoV-2 infection, existing literature suggests.
Researchers Turn to Crowdsourcing to Learn More About COVID-19 and Cancer
Pooling data from physicians and patients appears to be an efficient way to answer urgent questions.
- Loading...
Loading...
Next post in General Oncology
Loading... 
Loading...